Pictet Asset Management (UK)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$49.7M Sell
207,161
-20,754
-9% -$2.28M 0.05% 343
2021
Q1
$45.6M Buy
+227,915
New +$22.9M 0.05% 346
2016
Q3
Sell
-107,746
Closed -$6.4M 831
2016
Q2
$6.4M Buy
+107,746
New +$6.26M 0.03% 525

Other funds holding AZN

Pictet Asset Management (UK)'s AZN Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its AstraZeneca (AZN) stake by 9.1% in Q2 2021, selling an estimated $2.28M and leaving 207,161 shares worth $49.7M. The position accounts for 0.05% of the portfolio, ranked #343.

Pictet Asset Management (UK) first reported a position in AZN in Q2 2016 and has held it in 3 quarters since. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

  • Pictet Asset Management (UK) held 207,161 shares of AstraZeneca worth $49.7M as of Q2 2021.
  • Pictet Asset Management (UK) sold 20,754 AstraZeneca shares in Q2 2021, an estimated $2.28M.
  • AstraZeneca made up 0.05% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #343 holding.
  • Pictet Asset Management (UK) first reported a position in AstraZeneca in Q2 2016 and has held it in 3 quarters since.
  • 771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.